1. Man in't Veld AJ, Schalekamp MADH (1983) Effects of 10 different beta-adrenoceptor antagonists on hemodynamics, plasma renin activity and plasma norepinephrine in hypertension. They key role of vascular resistance changes in relation to partial agonist activity. J Cardiovasc Pharmacol 5 [Suppl 1]: 530?540
2. Takenaka T, Tachikawa S (1972) Beta-adrenergic blocking and cardiovascular properties of a new compound, 1-(7-indenyloxy)-3-isopropylaminopropan-2-ol-hydrochloride (YB-2). Arzneimittelforsch 22: 1864?1869
3. Tachikawa S, Takenaka T (1973) Pharmacological studies on 1-(7-indenyloxy)-3-isopropylaminopropan-2-ol-hydrochloride (YB-2), a new beta-adrenergic blocking agent. Arch Int Pharmacodyn Ther 202: 79?82
4. Zuccari G, Falcone A, Turba C (1986) Acute effect of Indenolol on systemic arterial pressure and heart rate in the rat. Pharmacol Res Commun (in press)
5. Okupa FE, Daneshmend TK, Shrobsbree E, Roberts CJC (1981) Dose-response studies of indenolol, a beta-adrenoceptor blocker. Clin Pharmacol Ther 29: 434?439